Skip to main content
Premium Trial:

Request an Annual Quote

Courtagen Life Sciences' rxSEEK Epilepsy

Courtagen Life Sciences has launched its rxSEEK Epilepsy genetic test to identify an individual’s susceptibility to adverse effects of anti-epileptic drugs. The next-generation sequencing-based test analyzes the DNA sequences of certain liver enzyme genes involved in drug metabolism associated with 24 different seizure medications.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more